Add to ORKGTreatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications treatments that were often discordant with recommendations made in contemporary major treatment guidelines. Kulkarni et al. BMC Psychiatry 2012, 12:22
Context: Psychosocial interventions have been shown to enhance pharmacotherapy outcomes in bipolar d...
Introduction: We developed models of Specialized Care for Bipolar Disorder (SCBD) and a psychosocial...
Shattell and Keltner present a case for atypical antipsychotics in bipolar disorder. Moreover, they ...
Abstract Background The Bipolar Comprehensive Outcomes Study (BCOS) is a 2-year, prospective, non-in...
Background The Bipolar Comprehensive Outcomes Study (BCOS) is a 2-year, prospective, non-interventio...
Objective: To assess the prevalence of bipolar I and II disorders in an Australian population. Metho...
Schizophrenia and Bipolar Disorder are two psychiatric conditions of great interest in modern times,...
Distribution and trends in outpatient utilization of e psychopharmaceuticals schizophrenia and bipol...
Background: Most previous studies on concordance with treatment guidelines for bipolar disorder focu...
Full list of author information is available at the end of the articleBackground Bipolar disorder (B...
Multi-state outcome analysis of treatments (MOAT): application of a new approach to evaluate outcome...
Abstract: Clozapine is an anti-psychotic used to treat refract-ory schizophrenia. This study review...
Objective: To evaluate the clinical correlates of and types of naturalistic treatments associated wi...
Bipolar disorder (BD) is a chronic disease with high risk of relapse. This disease also results in a...
Mallik Greene,1 Luciano Paladini,2 Teresa Lemmer,2 Alexandra Piedade,2 Maelys Touya,3 Otavio Clark2 ...
Context: Psychosocial interventions have been shown to enhance pharmacotherapy outcomes in bipolar d...
Introduction: We developed models of Specialized Care for Bipolar Disorder (SCBD) and a psychosocial...
Shattell and Keltner present a case for atypical antipsychotics in bipolar disorder. Moreover, they ...
Abstract Background The Bipolar Comprehensive Outcomes Study (BCOS) is a 2-year, prospective, non-in...
Background The Bipolar Comprehensive Outcomes Study (BCOS) is a 2-year, prospective, non-interventio...
Objective: To assess the prevalence of bipolar I and II disorders in an Australian population. Metho...
Schizophrenia and Bipolar Disorder are two psychiatric conditions of great interest in modern times,...
Distribution and trends in outpatient utilization of e psychopharmaceuticals schizophrenia and bipol...
Background: Most previous studies on concordance with treatment guidelines for bipolar disorder focu...
Full list of author information is available at the end of the articleBackground Bipolar disorder (B...
Multi-state outcome analysis of treatments (MOAT): application of a new approach to evaluate outcome...
Abstract: Clozapine is an anti-psychotic used to treat refract-ory schizophrenia. This study review...
Objective: To evaluate the clinical correlates of and types of naturalistic treatments associated wi...
Bipolar disorder (BD) is a chronic disease with high risk of relapse. This disease also results in a...
Mallik Greene,1 Luciano Paladini,2 Teresa Lemmer,2 Alexandra Piedade,2 Maelys Touya,3 Otavio Clark2 ...
Context: Psychosocial interventions have been shown to enhance pharmacotherapy outcomes in bipolar d...
Introduction: We developed models of Specialized Care for Bipolar Disorder (SCBD) and a psychosocial...
Shattell and Keltner present a case for atypical antipsychotics in bipolar disorder. Moreover, they ...